JNJ supply chain intelligence for Johnson & Johnson: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
Johnson & Johnson (JNJ) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| GNMSF | Genmab A/S | 92% | Reciprocal relationship from GNMSF graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from GNMSF graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from GNMSF … |
| HBIO | Harvard Bioscience, Inc. | 92% | Reciprocal relationship from HBIO graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from HBIO graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from HBIO gra… |
| PTGX | Protagonist Therapeutics, Inc. | 92% | Reciprocal relationship from PTGX graph: The Company has earned a total of $ 387.5 million in non-refundable payments from JNJ under the JNJ License and Collaboration Agreement |
| GPK | Graphic Packaging Holding Company | 90% | Reciprocal relationship from GPK graph: Health/beauty customers include GlaxoSmithKline, Bayer, Johnson & Johnson, Abbott, Novartis, L’Oréal S.A., Proctor & Gamble, and Colgate. |
| IMERYS-TALC-AMERICA-INC | IMERYS-TALC-AMERICA-INC | 90% | In February 2019, the Company’s talc supplier, Imerys Talc America, Inc., and two of its affiliates, Imerys Talc Vermont, Inc. and Imerys Talc Canada, Inc. (collectively, Imerys), filed voluntary pet… |
| ABBV | AbbVie Inc. | 85% | Reciprocal relationship from ABBV graph: ended March 31, 2026 and $ 242 million for the three months ended March 31, 2025. Sales and marketing and development costs for the three months ended March 3… |
| ANIK | Anika Therapeutics, Inc. | 85% | Reciprocal relationship from ANIK graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from ANIK graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from ANIK gra… |
| CYPRUS-MINES-CORPORATION | CYPRUS-MINES-CORPORATION | 85% | In February 2021, Cyprus Mines Corporation (Cyprus), which sold certain talc mines and assets to Imerys, filed a voluntary petition for relief under Chapter 11 of the Bankruptcy Code in the Delaware … |
| PCRX | Pacira BioSciences, Inc. | 85% | Reciprocal relationship from PCRX graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from PCRX graph: 025, of which $ million are due in each of 2026 and 2027, $ million in 2028, … |
| ORGN | Origin Materials, Inc. | 80% | Reciprocal relationship from ORGN graph: HP Embalagens is a major Brazilian packaging company serving world-renowned brands such as Nestlé, Ferrero Rocher, 2 Natura, and Johnson & Johnson. |
| ACIU | AC Immune SA | 72% | Reciprocal relationship from ACIU graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from ACIU graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from ACIU gra… |
| ADGM | Adagio Medical Holdings, Inc. | 72% | Reciprocal relationship from ADGM graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from ADGM graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from ADGM gra… |
| ALC | Alcon Inc. | 72% | Reciprocal relationship from ALC graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from ALC graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from ALC graph:… |
| AMIX | Autonomix Medical, Inc. | 72% | Reciprocal relationship from AMIX graph: a limited number of regions or Key Opinion Leaders ("KOLs") to refine and optimize the commercial strategy prior to national and global deployment. Our commer… |
| AORT | Artivion, Inc. | 72% | Reciprocal relationship from AORT graph: r in Iran; however, it is difficult to predict the ultimate course of these conflicts and we may face business operations and supply chain disruptions as a re… |
| APLM | Apollomics, Inc. | 72% | Reciprocal relationship from APLM graph: y’s material breach (subject to specified conditions) or by CTTQ if the licensed patents (i) have been or are evidenced to be invalidated or (ii) have infring… |
| APT | Alpha Pro Tech, Ltd. | 72% | Reciprocal relationship from APT graph: Owens Corning and GAF for synthetic roof underlayment. Our major competitor in the medical and dental markets is Kimberly-Clark Corporation of Fort Worth, Texa… |
| ARGX | argenx SE | 72% | Reciprocal relationship from ARGX graph: lement our business strategy is subject to numerous risks that you should be aware of before making an investment decision. These risks are described more ful… |
| ASML | ASML Holding N.V. | 72% | Reciprocal relationship from ASML graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from ASML graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from ASML gra… |
| ATON | AlphaTON Capital Corp | 72% | Reciprocal relationship from ATON graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from ATON graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from ATON gra… |
| ATRA | Atara Biotherapeutics, Inc. | 72% | Reciprocal relationship from ATRA graph: elay in, or failure to obtain, regulatory approval of any of our product candidates. In addition, such failure could be the basis for the FDA to issue a warni… |
| AURA | Aura Biosciences, Inc. | 72% | Reciprocal relationship from AURA graph: rts of such third parties, which may not be successful. Further, if we enter into arrangements with third parties to perform sales and marketing services, our… |
| AVBP | ArriVent BioPharma, Inc. | 72% | Reciprocal relationship from AVBP graph: therwise prefer to develop and market ourselves. We also face substantial competition from multiple sources, including large and specialty pharmaceutical and … |
| AVTX | Avalo Therapeutics, Inc. | 72% | Reciprocal relationship from AVTX graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from AVTX graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from AVTX gra… |
| BCAX | Bicara Therapeutics Inc. | 72% | Reciprocal relationship from BCAX graph: inancial institutions where we maintain our cash, cash equivalents and marketable securities, there can be no assurance that we would be able to access uninsu… |
| BDRX | Biodexa Pharmaceuticals Plc | 72% | Reciprocal relationship from BDRX graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from BDRX graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from BDRX gra… |
| BLCO | Bausch + Lomb Corporation | 72% | Reciprocal relationship from BLCO graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from BLCO graph: itrust Generic Pricing Antitrust Litigation BHC and its subsidiaries, Oceansi… |
| BLLN | BillionToOne, Inc. | 72% | Reciprocal relationship from BLLN graph: l and criminal penalties, damages, fines, the curtailment or restructuring of operations and exclusion from participation in federal and state healthcare prog… |
| BLNK | Blink Charging Co. | 72% | Reciprocal relationship from BLNK graph: . We offer the HQ 200-M Level 2 charger for the mobile/emergency charging market which requires a portable charger to be used for roadside or other use cases … |
| BLRX | BioLineRx Ltd. | 72% | Reciprocal relationship from BLRX graph: required to make under our in-licensing agreements is comprised of various components that are paid commensurate with the progressive development and commerci… |
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| USGOV-DEPARTMENT-OF-DEFENSE | USGOV-DEPARTMENT-OF-DEFENSE | 95% | USAspending awards from Department of Defense: $4,319,296 across 9 awards. SPE2D625F1LZG 4569174801!2.7MM/3.5MM VA-LCP ANKLE; SPE2D625F2EMD 4569301060!2.7MM/3.5MM VA-LCP ELBOW; SPE2D625F13XT 45668464… |
| KVUE | Kenvue Inc. | 92% | Reciprocal relationship from KVUE graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from KVUE graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from KVUE gra… |
| RCEL | AVITA Medical, Inc. | 85% | Reciprocal relationship from RCEL graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from RCEL graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from RCEL gra… |
| TMCI | Treace Medical Concepts, Inc. | 80% | Reciprocal relationship from TMCI graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from TMCI graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from TMCI gra… |
| ABBV | AbbVie Inc. | 72% | Reciprocal relationship from ABBV graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from ABBV graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from ABBV gra… |
| ACIU | AC Immune SA | 72% | Reciprocal relationship from ACIU graph: ave achieved and our goal of a close working relationship with the regulatory agencies, in particular the FDA, are intended to facilitate expeditious executio… |
| ADGM | Adagio Medical Holdings, Inc. | 72% | Reciprocal relationship from ADGM graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from ADGM graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from ADGM gra… |
| ALC | Alcon Inc. | 72% | Reciprocal relationship from ALC graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from ALC graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from ALC graph:… |
| AMIX | Autonomix Medical, Inc. | 72% | Reciprocal relationship from AMIX graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from AMIX graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from AMIX gra… |
| ANIK | Anika Therapeutics, Inc. | 72% | Reciprocal relationship from ANIK graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from ANIK graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from ANIK gra… |
| AORT | Artivion, Inc. | 72% | Reciprocal relationship from AORT graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from AORT graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from AORT gra… |
| APT | Alpha Pro Tech, Ltd. | 72% | Reciprocal relationship from APT graph: We manufacture, cut, warehouse and ship disposable protective apparel products and face shields in a 137,500 square foot facility in Nogales, Arizona. The majo… |
| ATNM | Actinium Pharmaceuticals, Inc. | 72% | Reciprocal relationship from ATNM graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from ATNM graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from ATNM gra… |
| BDRX | Biodexa Pharmaceuticals Plc | 72% | Reciprocal relationship from BDRX graph: with the objectives of safeguarding the health and wellbeing of our staff members and monitoring the impact on our vendors and collaborators. Beginning in mid… |
| BLRX | BioLineRx Ltd. | 72% | Reciprocal relationship from BLRX graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from BLRX graph: rsuant to the terms of a supply agreement to be negotiated in good faith with… |
| CANF | Can-Fite BioPharma Ltd. | 72% | Reciprocal relationship from CANF graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from CANF graph: ient, or API, through a leading Chinese contract research organization, or CR… |
| CINT | CI&T Inc. | 72% | Reciprocal relationship from CINT graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from CINT graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from CINT gra… |
| CLGN | CollPlant Biotechnologies Ltd. | 72% | Reciprocal relationship from CLGN graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from CLGN graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from CLGN gra… |
| CRSP | CRISPR Therapeutics AG | 72% | Reciprocal relationship from CRSP graph: eline. We believe it has the capacity to support, in whole or in part, the manufacture and supply of product for certain of our current clinical programs with… |
| CVRX | CVRx, Inc. | 72% | Reciprocal relationship from CVRX graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from CVRX graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from CVRX gra… |
| CYCN | Cyclerion Therapeutics, Inc. | 72% | Reciprocal relationship from CYCN graph: rovides for the attachment of an additional six months of marketing protection to the term of any existing regulatory exclusivity for both drugs and biologics… |
| CYTOF | Altamira Therapeutics Ltd. | 72% | Reciprocal relationship from CYTOF graph: nclude Acuitas Therapeutics Inc., Andros Pharmaceuticals Co., Ltd., Aro Biotherapeutics, Avidity Biosciences, Inc., Bio-Path Holdings, Inc., Chimeron Bio Inc… |
| ENGN | enGene Therapeutics Inc. | 72% | Reciprocal relationship from ENGN graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from ENGN graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from ENGN gra… |
| ENGNW | ENGNW | 72% | Reciprocal relationship from ENGNW graph: nts, drug substance and drug product are currently manufactured at cGMP-compliant CMOs at a scale that we believe can meet our needs for a commercial launch … |
| ESTA | Establishment Labs Holdings Inc. | 72% | Reciprocal relationship from ESTA graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from ESTA graph: Mentor Worldwide LLC (a division of Johnson & Johnson) and Allergan plc (acqu… |
| EVAX | Evaxion A/S | 72% | Reciprocal relationship from EVAX graph: g Phase 2b trial, we are required to pay to SSI a percentage of any sublicensing income in the mid double-digit range. Prior to any out-licensing or commercia… |
| EVFM | Evofem Biosciences, Inc. | 72% | Reciprocal relationship from EVFM graph: umber of sales employees; this negatively impacted our ability to maintain our sales and marketing capabilities. Any failure or future delay in the timely dev… |
| FCX | Freeport-McMoRan Inc. | 72% | Reciprocal relationship from FCX graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from FCX graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from FCX graph:… |
| GLSI | Greenwich LifeSciences, Inc. | 72% | Reciprocal relationship from GLSI graph: duct candidate and the average exposure time in the clinical development program may be inadequate to detect rare adverse events or chance findings that may o… |
| GMAB | Genmab A/S | 72% | Reciprocal relationship from GMAB graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from GMAB graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from GMAB gra… |
| Instrument | Description | Confidence | Evidence |
|---|---|---|---|
| JNJ-DEBT-6640 | Xbrl Convertible | 90% | xbrl convertible detail from xbrl 2023-01-01. |
| JNJ-DEBT | Debt stack $45.8B | 90% | Market cache reports total debt of $45.8B. |
| Holder | Name | Confidence | Evidence |
|---|---|---|---|
| JNJ-OWNER-GEODE-CAPITAL-MANAGEMENT-LLC | Geode Capital Management, LLC | 95% | 13F/ownership overlay lists Geode Capital Management, LLC; shares held 57,953,747; ownership 2.41%; value $14.1B; as of 2025-12-31. |
| JNJ-OWNER-VANGUARD-GROUP-INC | Vanguard Group Inc | 95% | 13F/ownership overlay lists Vanguard Group Inc; shares held 240,349,660; ownership 9.98%; value $58.5B; as of 2025-12-31. |
| JNJ-OWNER-STATE-STREET-CORPORATION | State Street Corporation | 95% | 13F/ownership overlay lists State Street Corporation; shares held 132,206,061; ownership 5.49%; value $32.2B; as of 2025-09-30. |
| JNJ-OWNER-BANK-OF-AMERICA-CORPORATION | Bank of America Corporation | 95% | 13F/ownership overlay lists Bank of America Corporation; shares held 28,419,787; ownership 1.18%; value $6.9B; as of 2025-09-30. |
| JNJ-OWNER-STATE-FARM-MUTUAL-AUTOMOBILE-INSURANCE-C | State Farm Mutual Automobile Insurance Co | 95% | 13F/ownership overlay lists State Farm Mutual Automobile Insurance Co; shares held 31,590,952; ownership 1.31%; value $7.7B; as of 2025-12-31. |
| JNJ-OWNER-MORGAN-STANLEY | Morgan Stanley | 95% | 13F/ownership overlay lists Morgan Stanley; shares held 48,231,667; ownership 2.00%; value $11.7B; as of 2025-09-30. |
| JNJ-OWNER-JPMORGAN-CHASE-CO | JPMORGAN CHASE & CO | 95% | 13F/ownership overlay lists JPMORGAN CHASE & CO; shares held 58,558,238; ownership 2.43%; value $14.3B; as of 2025-12-31. |
| JNJ-OWNER-NORTHERN-TRUST-CORPORATION | Northern Trust Corporation | 95% | 13F/ownership overlay lists Northern Trust Corporation; shares held 29,972,551; ownership 1.24%; value $7.3B; as of 2025-09-30. |
| JNJ-OWNER-BLACKROCK-INC | Blackrock Inc. | 95% | 13F/ownership overlay lists Blackrock Inc.; shares held 208,781,159; ownership 8.67%; value $50.8B; as of 2025-12-31. |
| JNJ-OWNER-NORGES-BANK | NORGES BANK | 95% | 13F/ownership overlay lists NORGES BANK; shares held 33,459,884; ownership 1.39%; value $8.1B; as of 2025-12-31. |
| JNJ-OWNER-JOHNSON-JOHNSON | JOHNSON & JOHNSON | 90% | 13F overlay lists JOHNSON & JOHNSON as top holder; 101 tracked holders. |
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|---|---|---|---|
| AORT | Artivion, Inc. | 100.00 | 1 | ['customer', 'supplier'] |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | 100.00 | 2 | |
| AXSM | Axsome Therapeutics, Inc. | 100.00 | 2 | |
| DAWN | Day One Biopharmaceuticals Inc | 100.00 | 2 | |
| AVBP | ArriVent BioPharma, Inc. | 100.00 | 1 | ['supplier'] |
| CRARF | Crédit Agricole S.A. | 100.00 | 2 | |
| ANIK | Anika Therapeutics, Inc. | 100.00 | 1 | ['customer', 'supplier'] |
| CLYM | Climb Bio, Inc. | 100.00 | 2 | |
| AUTL | Autolus Therapeutics plc | 100.00 | 2 | |
| BPTH | Bio-Path Holdings, Inc. | 100.00 | 2 | |
| BLLN | BillionToOne, Inc. | 100.00 | 1 | ['supplier'] |
| AURX | Nuo Therapeutics, Inc. | 100.00 | 2 | |
| AGM | Federal Agricultural Mortgage Corporation | 100.00 | 2 | |
| BSX | Boston Scientific Corporation | 100.00 | 2 | |
| CTNM | Contineum Therapeutics, Inc. | 100.00 | 2 | |
| BLNK | Blink Charging Co. | 100.00 | 1 | ['supplier'] |
| CYCN | Cyclerion Therapeutics, Inc. | 100.00 | 1 | ['customer'] |
| CTSH | Cognizant Technology Solutions Corporation | 100.00 | 2 | |
| BORAY | Bora Pharmaceuticals Co., Ltd. | 100.00 | 2 | |
| CRBU | Caribou Biosciences, Inc. | 100.00 | 2 |